| The international classification of headache disorders, (beta version) Headache Classification Committee of the International Headache Society (IHS) Cephalalgia 33 (9), 629-808, 2013 | 12299 | 2013 |
| Migraine—current understanding and treatment PJ Goadsby, RB Lipton, MD Ferrari New England journal of medicine 346 (4), 257-270, 2002 | 2582 | 2002 |
| Vasoactive peptide release in the extracerebral circulation of humans during migraine headache PJ Goadsby, L Edvinsson, R Ekman Annals of Neurology: Official Journal of the American Neurological …, 1990 | 1882 | 1990 |
| Pathophysiology of migraine: a disorder of sensory processing PJ Goadsby, PR Holland, M Martins-Oliveira, J Hoffmann, C Schankin, ... Physiological reviews 97 (2), 553-622, 2017 | 1798 | 2017 |
| Calcitonin gene–related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine J Olesen, HC Diener, IW Husstedt, PJ Goadsby, D Hall, U Meier, ... New England Journal of Medicine 350 (11), 1104-1110, 2004 | 1409 | 2004 |
| Hypothalamic activation in cluster headache attacks A May, A Bahra, C Büchel, RSJ Frackowiak, PJ Goadsby The Lancet 352 (9124), 275-278, 1998 | 1359 | 1998 |
| The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats PJ Goadsby, L Edvinsson Annals of Neurology: Official Journal of the American Neurological …, 1993 | 1354 | 1993 |
| Headache classification committee of the international headache society (IHS) the international classification of headache disorders J Olesen Cephalalgia 38 (1), 1-211, 2018 | 1296 | 2018 |
| OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial HC Diener, DW Dodick, SK Aurora, CC Turkel, RE DeGryse, RB Lipton, ... Cephalalgia 30 (7), 804-814, 2010 | 1276* | 2010 |
| Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials MD Ferrari, KI Roon, RB Lipton, PJ Goadsby The Lancet 358 (9294), 1668-1675, 2001 | 1264 | 2001 |
| The mechanism and management of headache JW Lance (No Title), 2005 | 1191 | 2005 |
| Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system PJ Goadsby, L Edvinsson, R Ekman Annals of Neurology: Official Journal of the American Neurological …, 1988 | 1096 | 1988 |
| New appendix criteria open for a broader concept of chronic migraine J Olesen, MG Bousser, HC Diener, D Dodick, M First, PJ Goadsby, ... Cephalalgia 26 (6), 742-746, 2006 | 1092 | 2006 |
| EFNS guideline on the drug treatment of migraine–revised report of an EFNS task force S Evers, J Afra, A Frese, PJ Goadsby, M Linde, A May, PS Sándor European journal of neurology 16 (9), 968-981, 2009 | 1039 | 2009 |
| A controlled trial of erenumab for episodic migraine PJ Goadsby, U Reuter, Y Hallström, G Broessner, JH Bonner, F Zhang, ... New England Journal of Medicine 377 (22), 2123-2132, 2017 | 980 | 2017 |
| A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. PJ Goadsby, RB Lipton Brain: a journal of neurology 120 (1), 193-209, 1997 | 976 | 1997 |
| Fremanezumab for the preventive treatment of chronic migraine SD Silberstein, DW Dodick, ME Bigal, PP Yeung, PJ Goadsby, ... New England Journal of Medicine 377 (22), 2113-2122, 2017 | 833 | 2017 |
| Premonitory symptoms in migraine: an electronic diary study NJ Giffin, L Ruggiero, RB Lipton, SD Silberstein, JF Tvedskov, J Olesen, ... Neurology 60 (6), 935-940, 2003 | 831 | 2003 |
| Human in vivo evidence for trigeminovascular activation in cluster headache Neuropeptide changes and effects of acute attacks therapies PJ Goadsby, L Edvinsson Brain 117 (3), 427-434, 1994 | 814 | 1994 |
| Brainstem activation specific to migraine headache A Bahra, MS Matharu, C Buchel, RSJ Frackowiak, PJ Goadsby The lancet 357 (9261), 1016-1017, 2001 | 767 | 2001 |